Evolution of clinical guidelines for antimicrobial management of Clostridioides difficile infection

Clostridioides difficile infection (CDI) has been an epidemic for many years. Our biggest challenge in treating CDI is preventing recurrence, which is seen in approximately 25% of patients with initial infection and in 40–60% of those with subsequent episodes. Given the major disease burden of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaar, Abdelkader, Feuerstadt, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Clostridioides difficile Infections: Approaching a Difficult Menace in 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111514/
https://www.ncbi.nlm.nih.gov/pubmed/33995583
http://dx.doi.org/10.1177/17562848211011953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111514/
https://www.ncbi.nlm.nih.gov/pubmed/33995583
http://dx.doi.org/10.1177/17562848211011953

Ejemplares similares